Clinical Trials Logo

Glaucoma, Suspect clinical trials

View clinical trials related to Glaucoma, Suspect.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06388096 Recruiting - Glaucoma, Suspect Clinical Trials

CLAD Deconvolved PERG Responses in Glaucoma Patients

Start date: June 1, 2023
Phase:
Study type: Observational

Glaucoma is a progressive disease resulting in blindness. Determining the onset of the disease is critical so patients may obtain treatment to preserve useful vision. This study will collect data from a population of glaucoma suspects (with positive factors for the disease but with normal vision) along with a population of age matched controls using the pattern electroretinogram (PERG) and other standard eye tests for glaucoma. The PERG measures the function of retinal ganglion cells (RGCs) which come together to form the optic nerve. RGCs may become dysfunctional before dying. The Continuous loop deconvolution technique (CLAD) will be used to extract transient PERG responses in both glaucoma suspects and age matched controls. All patients will be monitored with PERG, Optic Coherence Tomography (OCT) and other ancillary tests over 2 years. CLAD will be compared with conventional techniques of monitoring glaucoma (standard PERG, OCT, visual field etc) to see if the CLAD is better at distinguishing between glaucoma suspects and controls.

NCT ID: NCT05850936 Recruiting - High Myopia Clinical Trials

Effect of IOP Lowering on Progressive HM

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Currently, whether and when intraocular pressure (IOP) lowering medication should be used in progressive high myopia (HM) to control axial elongation is still a dilemma. Randomized trials are required to evaluate whether IOP lowering influences the growth of axial length in progressive HM eyes.

NCT ID: NCT05670015 Recruiting - Glaucoma, Suspect Clinical Trials

Ocular Changes With Alpha-2 Receptor Agonist.

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

selective alpha-2 receptor agonists cause changes in intraocular pressure and pupillary size thus may affect patient quality of life.

NCT ID: NCT05352906 Recruiting - Glaucoma Clinical Trials

Accuracy of Handheld and Non-contact Tonometry

Start date: April 20, 2022
Phase: N/A
Study type: Interventional

Monitoring the intraocular pressure (IOP) is one of the most important tests used in follow-up among glaucoma suspects and confirmed glaucomatous patients.

NCT ID: NCT05328921 Recruiting - Hypertension Clinical Trials

Effects of Systemic Drugs on Intraocular Pressure

Start date: April 7, 2022
Phase:
Study type: Observational

To assess intraocular pressure changes among glaucoma patients on systemic antihypertensive and antihistaminic drugs.

NCT ID: NCT05279716 Recruiting - Ocular Hypertension Clinical Trials

Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl

NOPAPS
Start date: February 15, 2022
Phase: Phase 4
Study type: Interventional

This study is for patients have been using prostaglandin analogue eye drops with a preservative for 3 months or more and have been diagnosed with prostaglandin-associated peri-orbital disease. the investigators would like to confirm the real world evidence(RWE) of safety and efficacy after changing to Eybelis ophthalmic solution 0.002%.

NCT ID: NCT05235321 Recruiting - Glaucoma Clinical Trials

Automated Applanation Tonometry

Start date: November 21, 2022
Phase: N/A
Study type: Interventional

Goldmann Applanation Tonometry (GAT) is considered the clinical gold standard for eye pressure measurements and yet it is known to be a subjective measurement with limited repeatability and limited portability. The purpose of this study is to develop an automated and objective method for performing applanation tonometry using standard ophthalmic equipment as well as using 2 portable prototypes.

NCT ID: NCT04433702 Recruiting - Glaucoma Clinical Trials

Effect of Negative Pressure on Pattern Electroretinography Readings

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Glaucoma is a leading cause of blindness worldwide. Intraocular pressure (IOP) remains the only modifiable risk factor for glaucoma. Without sufficient IOP lowering therapy, glaucoma induces retinal ganglion cell death and visual field loss. Pattern electroretinography (pERG) measurements directly correlate with retinal ganglion cell (RGC) signaling, providing an objective, repeatable, and non-invasive assessment of RGC function. The purpose of the study is to investigate the pERG changes associated with acute IOP reduction using the Mercury™ Multi-Pressure Dial (MPD). 10 patients will be enrolled. These subjects will have a best corrected visual acuity of 20/40 or better in both eyes and an established diagnosis of one of either mild/moderate OAG (open-angle glaucoma), OHT (ocular hypertension), or glaucoma suspect. Both eyes will be enrolled in the study. The study eye will receive a standardized 10 mmHg decrease in periorbital pressure via the Mercury™ Multi-Pressure Dial (MPD), and the fellow/control eye will receive no (zero) pressure application. Total google wear time will be 4.5 hours. Serial pERG measurements will be taken before, immediately after, and 2 hours after negative pressure application.

NCT ID: NCT04296916 Recruiting - High Myopia Clinical Trials

Effect of Lowering IOP in Glaucoma Suspects With HM

GSHM
Start date: April 17, 2020
Phase: N/A
Study type: Interventional

Currently, whether and when intraocular pressure (IOP) lowering medication should be used in glaucoma suspects with high myopia (HM) is still a dilemma. Randomized trials are required to evaluate whether IOP lowering influences the incidence of glaucoma suspect progression in HM eyes.

NCT ID: NCT03972852 Recruiting - Anesthesia Clinical Trials

Establishment of an Anaesthetic Protocol for Examinations for Children With Glaucoma or Suspected Glaucoma

eyeBIS
Start date: June 1, 2019
Phase:
Study type: Observational

Correct measurement of the intraocular pressure of children with glaucoma or suspected glaucoma is essential for diagnosis and therapy. Despite new non-invasive measurement methods most of the children are uncooperative during the ophthalmological examination. Therefore examination under anaesthesia is needed. A lot of perioperative factors influence the measurement of intraocular pressure. Established and safe anaesthetic regimes have been modified regarding these factors. Aim of the study is to evaluate, if a standardized anaesthetic protocol generates reliable and reproducible measured values.